Insiders · QCLS

QCLS insider transactions

Q/C Technologies Inc. (QCLS) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

QCLS insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Q/C Technologies Inc., latest first. Follow anyone to get their next filing.

• Joshua SilvermanExecutive Chairman, Director+$103K
• Yossef EhrlichmanChief Technology Officer, since September 2026
• Charles Todd FaganChief Financial Officer, since August 2026
• Chelsea Sierra VossDirector, since January 2026+$5,522
• Stephen FrisciaDirector, since June 2024
• Billy Joe WhiteDirector
• Mitchell GlassChief Medical Officer, Director, since April 2024
• Bruce BernsteinDirector, since September 2025
• PharmaCyte Biotech, Inc.10% owner, since May 2024
• Gary M RauchVice President of Finance
• Ian RhodesInterim CFO, since February 2021
• Paul RivardOfficer, since April 2021+$300K
• Adam KaplinOfficer, since April 2021
• Christopher C Chapman JROfficer, Director, since April 2021
• Jude UzonwanneDirector, since April 2021
• Craig EagleDirector, since April 2021
• Christopher C SchreiberDirector
• Caroline C Williams10% owner, since April 2021
• Robert C SchroederDirector

Recent Form 3, 4, and 5 filings for QCLS

• 38d
  Executive Chairman Silverman Joshua was granted 94,010 shares, increasing direct ownership by 80% to 210,845 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 38d
  Amendment: Executive Chairman Silverman Joshua was granted 16,806 shares, increasing direct ownership by 17% to 116,835 units (SEC Form 4)

  4/A - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 48d
  SEC Form 3 filed by new insider Ehrlichman Yossef

  3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 83d
  SEC Form 3 filed by new insider Fagan Charles Todd

  3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 178d
  Director Voss Chelsea Sierra bought $5,522 worth of shares (1,753 units at $3.15) (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by White Billy Joe

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by Friscia Stephen

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by Voss Chelsea Sierra

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by Bernstein Bruce

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by Glass Mitchell

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 207d
  SEC Form 4 filed by Silverman Joshua

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 282d
  Director Voss Chelsea Sierra was granted 237,500 shares, increasing direct ownership by 9,896% to 239,900 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 282d
  New insider Voss Chelsea Sierra claimed ownership of 62,202 shares (SEC Form 3)

  3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 355d
  SEC Form 4 filed by Large owner Pharmacyte Biotech, Inc.

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 356d
  Director White Billy Joe was granted 22,839 shares, increasing direct ownership by 1,045% to 25,024 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 356d
  Director, Chief Medical Off. Glass Mitchell was granted 11,420 shares, increasing direct ownership by 1,057% to 12,500 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 359d
  Executive Chairman Silverman Joshua was granted 91,356 shares, increasing direct ownership by 1,053% to 100,029 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 359d
  Director Friscia Stephen was granted 22,839 shares, increasing direct ownership by 1,057% to 25,000 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 359d
  Director Bernstein Bruce was granted 25,000 shares (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 359d
  Vice President of Finance Rauch Gary M was granted 11,420 shares, increasing direct ownership by 1,057% to 12,500 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  New insider Bernstein Bruce claimed ownership of 23 shares (SEC Form 3)

  3 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  Executive Chairman Silverman Joshua was granted 8,644 shares, increasing direct ownership by 29,807% to 8,673 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  Director Friscia Stephen was granted 2,161 shares (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  Director White Billy Joe was granted 2,161 shares, increasing direct ownership by 9,004% to 2,185 units (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  Director, Chief Medical Off. Glass Mitchell was granted 1,080 shares (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)
• 398d
  Vice President of Finance Rauch Gary M was granted 1,080 shares (SEC Form 4)

  4 - Q/C TECHNOLOGIES, INC. (0001321834) (Issuer)